I/LA20
Analytical Performance Characteristics, Quality Assurance, and Clinical Utility of Immunological Assays for Human Immunoglobulin E Antibodies of Defined Allergen Specificities, 3rd Edition
Give your laboratory staff the guidance they need for the design, analytical performance, standardization, quality assurance, and clinical application of laboratory assays used in the measurement of human immunoglobulin E antibodies of defined allergen specificity.
Supplemental data for I/LA20 are published in CLSI database I/LA37.
This edition of the document was corrected in December 2016. Read the full correction notice here, and learn more about our corrections process here.
This document is available in electronic format only.
Member price:
Nonmembers:Details
Chairholder: Robert G. Hamilton, PhD, D.ABMLI and Per N. J. Matsson, PhD
Date of Publication: October 24, 2016
Order Code PDF: ILA20Ed3E
ISBN Number: 1-56238-949-1
Order Code Print: print not available
Edition: Third
Pages: 120
I/LA20 Additional Details
The U.S. Food and Drug Administration (FDA) has evaluated and recognized this approved-level consensus standard for use in satisfying a regulatory requirement.